These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27255707)

  • 1. Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.
    Chen Y; Bai Y; Guo X; Wang W; Zheng Q; Wang F; Sun D; Li D; Ren G; Yin J
    Biologicals; 2016 Jul; 44(4):271-275. PubMed ID: 27255707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity maturation of an anti-hepatitis B virus PreS1 humanized antibody by phage display.
    Yang GH; Yoon SO; Jang MH; Hong HJ
    J Microbiol; 2007 Dec; 45(6):528-33. PubMed ID: 18176536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
    Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
    J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
    Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
    J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of neutralizing activity of human scFv antibodies against hepatitis B virus binding using CDR3 V(H) mutant library.
    Park SG; Jung YJ; Lee YY; Yang CM; Kim IJ; Chung JH; Kim IS; Lee YJ; Park SJ; Lee JN; Seo SK; Park YH; Choi IH
    Viral Immunol; 2006; 19(1):115-23. PubMed ID: 16553557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus-neutralizing anti-pre-S1 human antibody fragments from large naïve antibody phage library.
    Park SG; Jeong YJ; Lee YY; Kim IJ; Seo SK; Kim EJ; Jung HC; Pan JG; Park SJ; Lee YJ; Kim IS; Choi IH
    Antiviral Res; 2005 Dec; 68(3):109-15. PubMed ID: 16290278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of high affinity human single-chain antibody against PreS1 of hepatitis B virus from immune phage-display antibody library.
    Zhang ZC; Hu XJ; Yang Q
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):77-81. PubMed ID: 14969843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of phage display antibody library to MCF-7 cells and screening of single-chain antibodies against breast cancer cells].
    Zhao Y; Wang QM; Fu XQ; Chen JZ; Fan GC; Chen HP
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):667-72. PubMed ID: 15973987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligation-based assembly for constructing mouse synthetic scFv libraries by chain shuffling with in vivo-amplified VH and VL fragments.
    Nishi M; Jian N; Yamamoto K; Seto H; Nishida Y; Tonoyama Y; Shimizu N; Nishi Y
    J Immunol Methods; 2014 Oct; 412():53-69. PubMed ID: 25010461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals.
    Sankhyan A; Sharma C; Dutta D; Sharma T; Chosdol K; Wakita T; Watashi K; Awasthi A; Acharya SK; Khanna N; Tiwari A; Sinha S
    Sci Rep; 2016 Feb; 6():21240. PubMed ID: 26888694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ribosome display screening of a novel human anti-IgE scFv fragment].
    Zhang YX; Wang BC; Yu X; Dai YJ; He YZ; Cong C; Xia Y; Wang MR
    Yao Xue Xue Bao; 2012 Oct; 47(10):1329-35. PubMed ID: 23289145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes.
    Kato M; Hanyu Y
    J Immunol Methods; 2013 Oct; 396(1-2):15-22. PubMed ID: 23916870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
    Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
    Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.
    Zhai W; Davies J; Shang DZ; Chan SW; Allain JP
    J Viral Hepat; 1999 Mar; 6(2):115-24. PubMed ID: 10607222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generation of high affinity humanized single-chain antibody against PreS1 of hepatitis B virus from immune phage displayed antibody library].
    Zhang ZC; Li Q; Hu XJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):90-2. PubMed ID: 12648402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neutralizing scFv antibody against infectious bursal disease virus screened by flow cytometry.
    Zhou Y; Xie ZG
    J Immunol Methods; 2015 Sep; 424():80-4. PubMed ID: 26003676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
    Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
    MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.